Trials / Completed
CompletedNCT01235871
A Single and Multiple-Dose Study of SB1578
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Ascending Single and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SB1578 When Administered Orally to Healthy Adult Subjects With One Single-Dose Group Crossing Over to Assess Food Effect
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- S*BIO · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine the safety, tolerability, pharmacokinetics and pharmacodynamics of SB1578 in healthy volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SB1578 | JAK2 Inhibitor |
| DRUG | Placebo | Control arm |
Timeline
- Start date
- 2010-08-01
- Primary completion
- 2011-03-01
- Completion
- 2011-03-01
- First posted
- 2010-11-08
- Last updated
- 2012-04-20
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01235871. Inclusion in this directory is not an endorsement.